- Home
- Products
Braftovi (Encorafenib)
Braftovi (Encorafenib)
- Medicine Name: Braftovi
- Generic Name: Encorafenib
- Dosage Form & Strength: Capsules – 75 mg
- Manufactured By: Pfizer Inc.
Braftovi (Encorafenib) is a kinase inhibitor approved for use in combination therapies for various BRAF V600-mutant cancers:
- Melanoma: With binimetinib for unresectable or metastatic melanoma with BRAF V600E or V600K mutation
- Colorectal Cancer (CRC): With cetuximab for metastatic CRC with BRAF V600E mutation
- Non-Small Cell Lung Cancer (NSCLC): With binimetinib for metastatic NSCLC with BRAF V600E mutation
Limitations: Not recommended for wild-type BRAF tumors in melanoma, CRC, or NSCLC.
Recommended Dosage:
- Melanoma/NSCLC: 450 mg (six 75 mg capsules) once daily with binimetinib
- Colorectal Cancer: 300 mg (four 75 mg capsules) once daily with cetuximab
Take Braftovi with or without food. Avoid taking a missed dose within 12 hours of the next dose. Do not take an extra dose if vomiting occurs—resume with the next scheduled dose.
Secondary Skin Cancers: Regular skin exams recommended
Tumor Promotion in Wild-Type BRAF Tumors: Avoid use; confirm mutation status before treatment
Cardiomyopathy: Monitor cardiac function before and during treatment
Hepatotoxicity: Monitor liver function tests regularly
Serious Bleeding Events: Includes GI and intracranial hemorrhages
Ocular Toxicities: Includes uveitis and other inflammatory conditions; regular eye checkups advised
Reproductive Toxicity: Can cause fetal harm. Use contraception during and for 2 weeks after treatment. Avoid breastfeeding during and for 2 weeks after therapy
Required Documents for Import:
- Valid prescription from a qualified physician
- Patient’s diagnostic reports
- Government-issued ID proof
Order Confirmation:
- Confirmed upon receipt of prescription and import permit (if applicable)
Availability in India & Globally: Available in cities across India through Global Rare Meds – Mumbai, Delhi, Bangalore, Pune, Chennai, Hyderabad, Kolkata, Ahmedabad, and others. Also available in Gulf countries and SAARC nations (Afghanistan, Sri Lanka, Nepal, Bangladesh, etc.).
To Order or Enquire Price:
- Phone/WhatsApp: +91-99675 15602
- Email: info@globalraremeds.com
Global Rare Meds sources Braftovi from authorized suppliers in the US, Europe, Canada, and Australia. All prescriptions are validated by licensed pharmacists and shipped from our fulfillment center in Ambernath, Thane District.
We ensure compliance, transparency, and global reach.
What is the generic name of Braftovi®?
Encorafenib
Who manufactures Braftovi®?
Pfizer Inc.
Is Braftovi® FDA approved?
Yes. Approved on June 27, 2018
What is the dosage form of Braftovi®?
Capsules: 75 mg for oral use
Common side effects (with binimetinib):
Fatigue, nausea, vomiting, abdominal pain, arthralgia
Common side effects (with cetuximab):
Diarrhea, rash, fatigue, nausea, appetite loss, acneiform dermatitis
How much does Braftovi® cost in India?
Price may vary. Contact Global Rare Meds for latest pricing via WhatsApp at +91-99675 15602 or email info@globalraremeds.com
Can Braftovi® be made available in SAARC countries?
Yes. We assist in legal supply across India, Bangladesh, Nepal, Bhutan, Pakistan, and more
How should Braftovi® be stored?
Store at 20–25°C (68–77°F). Protect from moisture, dispense in the original container with intact safety seal
Is it safe to order Braftovi® online in India?
Yes. Global Rare Meds facilitates secure, legal import through proper regulatory channels
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
